AbbVie and Express Scripts are Paving the Way to Better Access to Hep C Treatment

The New York Times reports that a new deal between AbbVie Pharmaceuticals and Express Scripts will soon change the world of hepatitis C treatment.  This news comes on the heels of the announcement just this past Friday that AbbVie’s new hepatitis C combo treatment, Viekira Pak, has been approved by the FDA.

The full article can be found here.

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s